Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2010
05/27/2010US20100129377 Milk derived antigen-specific antibodies, methods of preparation and uses thereof
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129371 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
05/27/2010US20100129361 Immunosuppression with antibody against itm2a
05/27/2010US20100129360 Antibodies against human interleukin-13 and uses therefor
05/27/2010US20100129357 Antibodies to il-6 and use thereof
05/27/2010US20100129355 Therapeutic agents for ocular inflammatory disease comprising interleukin 6 receptor inhibitor as active ingredient
05/27/2010US20100129354 Intranasal delivery of polypeptides and proteins
05/27/2010US20100129350 Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives
05/27/2010US20100129339 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane
05/27/2010US20100129326 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
05/27/2010US20100129314 Potent conjugates and hydrophilic linkers
05/27/2010CA2781591A1 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone praticles as scaffolds for tissue regeneration
05/27/2010CA2781197A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010CA2744048A1 Single-time vaccines
05/27/2010CA2743950A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010CA2742946A1 Antioxidant
05/27/2010CA2740589A1 Compounds that expand hematopoietic stem cells
05/26/2010EP2189521A1 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same
05/26/2010EP2189475A2 Fibroblast growth factor-like polypeptides
05/26/2010EP2189445A1 Five-membered heterocyclic compound
05/26/2010EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions
05/26/2010EP2189162A1 Methods for the treatment of cellular proliferative disorders
05/26/2010EP2189156A1 Lys-Pro and Lys-Pro-Thr for the manufacture of a cosmetic composition
05/26/2010EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent
05/26/2010EP2187956A2 Use of a laminin peptide as a therapeutic agent
05/26/2010EP2187952A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents
05/26/2010EP2187950A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent
05/26/2010EP2187949A2 Use of glp-1 as a therapeutic agent
05/26/2010EP2187948A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187947A2 Use of calcitonin as anti-angiogenic agent
05/26/2010EP2187946A1 Use of a peptide as a therapeutic agent
05/26/2010EP2187934A1 Use of fertirelin and delta-endorphin as therapeutic agents
05/26/2010EP2187930A2 Trap-14 as a therapeutic agent
05/26/2010EP2187924A2 Use of a peptide as a therapeutic agent
05/26/2010EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent
05/26/2010EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent
05/26/2010EP2187909A1 Use of bpp-b as a therapeutic agent
05/26/2010EP2187907A2 Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
05/26/2010EP2187884A2 Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
05/26/2010EP1461325B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/26/2010EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies
05/26/2010EP1307225B1 Antagonists of cd30 or cd30l for use in treating auto-immune and chronic inflammatory conditions
05/26/2010CN1969814B Nasal administered preparation of melatonin
05/26/2010CN1930180B L-saccharide glucose lipid A analogue
05/26/2010CN1915991B Synthesis of indole thiazole compounds as ligands for the ah receptor
05/26/2010CN1870910B Synbiotic composition for infants
05/26/2010CN1845938B Polypeptides
05/26/2010CN1838967B Stabilized immunogenic HBc chimer particles
05/26/2010CN1814301B Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
05/26/2010CN1809531B Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
05/26/2010CN1798763B Phl p 5a derivatives with reduced allergenicity and retained T-cell reactivity
05/26/2010CN1756763B Dimerized peptide
05/26/2010CN1733296B Stable liquid interferon formulations
05/26/2010CN1681811B Azolidinone-vinyl fused-benzene derivatives
05/26/2010CN1671412B Immunostimulatory compositions and methods of stimulating an immune response
05/26/2010CN1671407B Compositions and methods for treating diabetes
05/26/2010CN1665934B GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1655823B Topically applicable pharmaceutical preparation
05/26/2010CN1646138B Novel therapeutical use of agonist ligands specific to G2A receptor
05/26/2010CN1604795B Combination motif immune stimulatory oligonucleotides with improved activity
05/26/2010CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
05/26/2010CN1518458B Graft rejection inhibitors
05/26/2010CN1468308B Anti-TNF antibodies, compositions, methods and uses
05/26/2010CN101712957A Toll-like receptor 9 (TLR9) blocking agent and application thereof
05/26/2010CN101712721A T cell receptor fusions and conjugates and methods of use thereof
05/26/2010CN101712720A Human antibodies that bind human TNF alpha
05/26/2010CN101712679A Acylamide class compound, medicine composition, preparation method and application thereof
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712618A Two crystal form materials of salvianolic acid A, preparation method as well as medicine compound and application thereof
05/26/2010CN101711862A Medicine target spot relevant to inflammatory diseases and application thereof
05/26/2010CN101711860A Application of laver phycobilin protein in preparing medicine used for resisting oxidation and enhancing immunity
05/26/2010CN101711833A Medicine composition for treating fatigue syndrome of sub-healthy people and hypodynamia and inferior immunologic function of patient with acquired immune deficiency syndrome and preparation method thereof
05/26/2010CN101711826A Traditional Chinese medicine composite for improving poulard productivity and application thereof
05/26/2010CN101711810A Preparation used for improving sleep and enhancing immunity
05/26/2010CN101711809A Medicine composition for treating postpartum melancholia, preparation method and application
05/26/2010CN101711806A Medicine for treating rheumatoid arthritis and preparation method thereof
05/26/2010CN101711803A Chinese herbal medicine bacteriostatic agent for treating refractory dermatosis and preparation method thereof
05/26/2010CN101711786A Preparation used for relieving osteoarthropathy and enhancing immunity
05/26/2010CN101711775A Fermentation composition for fermenting Agaricus blazei Murrill through probiotics
05/26/2010CN101711770A Fomitopsis officinalis (Vill. : Fr.) Bond. polysaccharide particle preparation and preparation method thereof
05/26/2010CN101711582A Composition containing American ginseng extract and probiotics and application thereof
05/26/2010CN101147807B Substances for preventing and treating autoimmune diseases
05/26/2010CN101081058B Heat-resisting stressed feed supplement and uses thereof
05/26/2010CN101058595B Ibonucleic acid, and preparation method and application thereof
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
05/26/2010CN101057976B Substances for preventing and treating autoimmune diseases
05/26/2010CN101023772B Gastrodia-walnut health-care sweet
05/26/2010CN101003528B Diterpene compound and derivative in kaurene class of new dissymmetry, and its preparation method and uses
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723482 Preventing CD28 binding to B7 by monovalent fragments antibody called CD28.3 of which exhibit sufficient affinity for the antigen so that they can be used, in vitro or in vivo, to block the CD28 receptor without activation of this receptor; autoimmune diseases; transplant rejection
05/25/2010US7723480 Leucine-based motif and clostridial neurotoxins
05/25/2010US7723479 BSL3 polypeptides
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1
1 ... 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 ... 1172